Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Coterra Energy Reports Third-Quarter 2025 Results, Announces Quarterly Dividend, and Provides Fourth-Quarter and Full Year 2025 Guidance Update
-
Magnachip Reports Results for Third Quarter 2025
-
Ameresco Reports Third Quarter 2025 Financial Results
-
Air Lease Announces Third Quarter 2025 Results
-
Eagle Bancorp, Inc. Announces Leadership Transition
-
Armada Hoffler Reports Third Quarter 2025 Results
-
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
-
Pixelworks to Announce Third Quarter 2025 Financial Results on November 11
-
Realty Income Announces Operating Results for the Three and Nine Months Ended September 30, 2025
-
AAVivo, Inc. to Present at Society for Immunotherapy of Cancer 2025
-
PLAYSTUDIOS, Inc. Announces Third Quarter Results
-
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Digital Realty Declares Quarterly Cash Dividend for Common and Preferred Stock
-
Digital Realty Advances AI Infrastructure Innovation Supporting NVIDIA AI Factory Research Center and NVIDIA DSX Blueprint
-
Paymentus Reports Third Quarter 2025 Financial Results
-
National Storage Affiliates Trust Announces Preferred Equity Investment in Newly Formed Joint Venture
-
International Battery Metals Ltd. Announces Promotion of Don Bender to Vice President of Technology
-
Bitterroot Bio to Present Anti-CD47 Research at American Heart Association Annual Scientific Session 2025
-
Ichor Holdings, Ltd. Announces Third Quarter 2025 Financial Results
-
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week
-
V2X Delivers Solid Third Quarter Results with Record Revenue
-
TrueBlue Reports Third Quarter 2025 Results
-
Exact Sciences Announces Third Quarter 2025 Results
-
Medifast Announces Third Quarter 2025 Financial Results
-
Reed’s Reports Third Quarter 2025 Results
-
Viant to Participate in Upcoming Investor Conferences
-
Simon® Reports Third Quarter 2025 Results
-
Superior Group of Companies Reports Third Quarter 2025 Results
-
Infinity Natural Resources Announces Third Quarter 2025 Results Earnings Release and Conference Call Dates
-
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
-
Fastenal Names New Chief Financial Officer and Senior Executive Vice President
-
Sterling Reports Record Third Quarter 2025 Results and Increases Full Year Guidance
-
REPAY to Attend Upcoming Investor Conferences
-
Virtus Total Return Fund Inc. Announces Commencement of Tender Offer
-
Addus HomeCare Announces Third Quarter 2025 Financial Results
-
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Palantir Reports Q3 2025 U.S. Comm Revenue Growth of 121% Y/Y and Revenue Growth of 63% Y/Y; Guides Q4 Revenue to 61% Y/Y and U.S. Comm Revenue to 121% Y/Y; Raises FY 2025 Revenue Guidance to 53% Y/Y,
-
ZoomInfo Announces Third Quarter 2025 Financial Results
-
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Myomo to Report Third Quarter 2025 Financial Results on November 10
-
RADIANT LOGISTICS TO HOST INVESTOR CALL TO DISCUSS FINANCIAL RESULTS FOR FIRST FISCAL QUARTER ENDED SEPTEMBER 30, 2025
-
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely
-
Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AAR acquires HAECO Americas and signs multi-year contracts with key customers, extending North American MRO leadership
-
Ormat Technologies Reports Third Quarter 2025 Financial Results
-
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
-
Savara Announces Participation in Upcoming Investor Healthcare Conferences
-
Gaia Reports Third Quarter 2025 Results

